Nuclear phospholipase C signaling through type 1 IGF receptor and its involvement in cell growth and differentiation

Anticancer Res. 2005 May-Jun;25(3B):2039-41.

Abstract

The existence of a nuclear polyphosphoinositol metabolism, independent from that at the plasma cell membrane, is now widely recognized. Specific changes in the nuclear phosphatidylinositol (PtdIns) metabolism have been implicated in cell growth, differentiation and neoplastic transformation. Here, the main features of nuclear inositol lipid signaling through type I IGF receptor, is reviewed with particular attention to the role of inositide-specific phospholipase C (PI-PLC) beta1 in cell proliferation and differentiation, due to the peculiar localization of this molecule in the nuclear compartment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Differentiation / physiology
  • Cell Growth Processes / physiology
  • Cell Nucleus / enzymology
  • Enzyme Activation
  • Insulin-Like Growth Factor I / pharmacology
  • Isoenzymes / metabolism*
  • Myoblasts / cytology
  • Myoblasts / enzymology
  • Myoblasts / metabolism
  • Phosphatidylinositols / metabolism
  • Phospholipase C beta
  • Receptor, IGF Type 1 / metabolism*
  • Signal Transduction / physiology
  • Type C Phospholipases / metabolism*

Substances

  • Isoenzymes
  • Phosphatidylinositols
  • Insulin-Like Growth Factor I
  • Receptor, IGF Type 1
  • Type C Phospholipases
  • Phospholipase C beta